Viatris heads into its May 7 Q1 earnings report with short sellers quietly adding exposure — even as the stock posts its best month in some time.
The most notable positioning shift is in short interest. Bears have added roughly 26% more short exposure over the past month, lifting SI to 3.2% of the float. The move has been concentrated in the second half of April, with shares short jumping from around 29 million to over 36 million between April 9 and April 27. That said, the borrow market remains entirely relaxed — cost to borrow is near 0.36%, well below typical stress levels, and availability is wide open. The lending pool shows no signs of constraint. This is deliberate positioning, not a forced trade.
Options tell a modestly more cautious story. The put/call ratio has drifted to 0.22, running above its 20-day average of 0.175 — roughly 1.3 standard deviations elevated. That's not an extreme reading against the 52-week range (the ratio has been as high as 0.74), but the direction of travel is clear: options traders have been gradually adding more downside protection since late April. The stock itself has helped set that tone. After a difficult February print — the last earnings triggered a 7% single-day drop and a nearly 10% five-day loss — the setup into May commands some respect. The May 7 report will follow a strong month for the stock, which has recovered roughly 13% to trade near $15.20.
The analyst picture is broadly constructive, if not uniformly so. Barclays raised its target to $17 in late March while maintaining an Overweight, and Argus upgraded to Buy in January. The consensus mean target sits around $15.94 — close to where the stock is now — which means the Street's collective upside case has largely been priced in by the recent rally. Davis Selected Advisers remains the most notable active holder, having added over 8.8 million shares in the most recent filing period, a meaningful signal of conviction at these levels. That stands in contrast to some lighter institutional activity elsewhere in the holder list and to the CCO selling shares at $13.86 in mid-April.
The May 7 print is therefore less a test of whether Viatris can stabilise its business and more a question of whether the company can offer forward visibility that justifies a stock now trading back near analyst consensus — with fresh shorts watching from the other side.
See the live data behind this article on ORTEX.
Open VTRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
